Member Info for Wildforce

Morning ! Do you not see anything else in there?

Take care ..

As an investor in scancells science , I’m reassured that Genmabs due diligence has resulted in a deal that Scancells board feel is fair value ..

That’s what I’m here for .. first of many? Who knows .. but scancells Aim valuation is certainly becoming a bit of an enigma !

Take care all !

Best wishes to RG .. I for one will miss him as a contact within scancell as he always replied promptly and within the rules to my e-mails !

Interesting that just the milestone payments on one of many products from one of scancells 4 platform technologies is worth more than scancells entire current market value ?

Lol is all I have to say!

Take care all !

Nice bit of news this morning ! Well done team scancell !!

Take care all ..

I think the question C7 was asking was why was it posted as a black trade … the algorithm surely would have said blue for that one !?

Take care ..

She is looking good … maybe she’s developed a vaccine against ageing based on the immunobody platform and she’s been testing it on herself !! Lol ..

Joking aside .. big congratulations to her for her achievements to date … and I don’t think she’s finished just yet !!

Take care all !

Agree with all that … but we do know that during this time there has been no reports of any concerning adverse events …

… and that is very good news ..

Take care all ..

Completely get your perspective .. but how much notice will we get of them doing any sort of ‘deal’ ?

They have expanded their intellectual property portfolio beyond recognition and are in the process of demonstrating it …

The wait continues …

Take care ..

Good to see the posters being published … I think we have to look at the bigger picture though, whether we ‘understand’ them or not, Lindy and her team thought they were worthy of publishing and presenting and also regarding Avidimab … it’s not just an idea, this technology is already in the clinic !

Markets are in turmoil so more opportunity coming perhaps !?

Take care all ..

Apols .. are the abstracts .. but not the posters ..

Page 50 ..

https://www.euromabnet.com/meeting/files/6th-Workshop-12th-EuroMAbNet-Book-Abstracts-2022.v1.pdf

Not the abstracts themselves but about the presentation ..

Take care all ..

As ever with scancell, the publication of new data comes with confidence that their technology is secure regarding the patents applied to it .. more progress that as yet has no value attached to it.

Fascinating!

Take care all ..

That’s an interesting read ! Thanks ..

“ Additionally, the PharmaJet NFIS overcame the drawbacks of electroporation, being easier to use and not requiring a power source.”

Take care all .

The support for scancell from people like Christian Ottensmeier is part of my decision to keep invested here. A very experienced clinician indeed .

Take care all..

I’m not sure if any company can manage their own clinical trial .. Scancell certainly arnt !

“Professor Christian Ottensmeier at The Clatterbridge Cancer Centre and University of Liverpool, commented: "I am very excited to be the principal investigator for this first-in-human clinical trial to determine if siPTMs and, in particular, citrullination will be able to transform the prognosis for these patients with hard to treat tumours."

Take care ..

Just catching up after a busy day ! That’s brilliant news C7 !!! Really pleased !! .. but also just heard the news about Olivia Newton John .. pretty gutted now too !! come on .. this dreadful disease desperately needs better solutions !!

Take care all !!

Not all long term holders are ‘sitting on losses’.

But maybe if it’s said enough it might be believed ? Who knows eh .. I’m looking forward to a discussion about scancell on here lol ..

Take care ..

One thing we can all be sure of … a working universal covid vaccine isn’t built into todays share price ! Lol ..

Take care all ..

Saying that though .. the part 1 section of the Scib1 trial in melanoma was extended to 5 years from 6 months pretty quickly due to the safety profile of the first cohorts of patients dosed ..

Understand your thought process though . We all hope it works for sure ! We just have to wait …

Take care ..

I’m not sure it is as simple as that … if it ‘works’ in the first person dosed in any trial it’s never reported until the whole trial is completed … However , if the first person dosed suffers a catastrophic reaction then that would have to be reported ..

Clinical trials need more than one positive result to take to the next stage but one complication could stop the trial in its tracks ..

All we know is that the trial is continuing .. for now ..

Take care ..